Invitae and Deerfield Management Partner to Create Novel Therapeutics for Rare Diseases

– The partnership will harness genetic and clinical data from millions of patients tested at Invitae and Deerfield’s expertise in drug discovery to address high unmet needs among rare disease patients – SAN FRANCISCO, March 22, 2023 /PRNewswire/ — Invitae (NYSE: NVTA), a leading medical…